Trial Profile
Absence of bismuth accumulation in patients prescribed pylera in real life setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 May 2019
Price :
$35
*
At a glance
- Drugs Tripotassium dicitrato bismuthate/tetracycline/metronidazole (Primary)
- Indications Helicobacter pylori infections
- Focus Adverse reactions; Pharmacokinetics
- Acronyms SAPHARY
- 08 May 2019 Results published in the Drug Safety
- 22 Sep 2017 New trial record
- 30 Aug 2017 Results presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management